Announcements
- MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024
- MannKind Repays Certain Debt Obligations
- MannKind Announces CFO Transition
- MannKind Corporation Announces Participation at Upcoming Conferences
- MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
- MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024
- MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
- MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
- MannKind Corporation Reports 2023 Third Quarter Financial Results
- MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.81 |
---|---|
High | 3.83 |
Low | 3.81 |
Bid | 3.86 |
Offer | 3.93 |
Previous close | 3.83 |
Average volume | -- |
---|---|
Shares outstanding | 270.68m |
Free float | 266.54m |
P/E (TTM) | -- |
Market cap | 1.19bn USD |
EPS (TTM) | -0.0464 USD |
Data delayed at least 15 minutes, as of May 04 2021.
More ▼